KBI Biopharma
KBI Biopharma is an award winning CDMO providing fully-integrated, accelerated drug development & biomanufacturing services to pharmaceutical & biotechnology companies globally
News releases
-
KBI Biopharma SA and Selexis SA Expand in Europe by Opening an Integrated Biologics Manufacturing...
KBI Biopharma and Selexis, announced today that an expanded, fully-integrated mammalian contract development and manufacturing services facility is now open and operational in Geneva, Swi...
-
JSR Life Sciences Appoints Veteran Biotech and CDMO Leader Mark W. Womack to Lead...
Womack will be responsible for the strategic vision, continued growth, and organizational culture of both organizations, which currently includes eight facilities in Europe and the US.
-
KBI Biopharma Holds Ribbon Cutting for New Commercial Manufacturing Facility
KBI, a JSR Life Sciences company, held a ribbon-cutting at the company’s new state-of-the-art $150 million, 150,000 square-foot commercial manufacturing facility in Research Triangle Park...
-
Oragenics Engages KBI Biopharma to Support Development of the Intranasal COVID-19 Vaccine Candida...
KBI to Produce Material for Use in Upcoming Phase 2 Clinical Trial of Oragenics’ Intranasal Vaccine Candidate
-
KBI Biopharma Completes Eurofins DiscoverX Products Specialized Bioassay Certification Program
Companies will work together on critical components that can accelerate client-sponsored validation programs through downstream drug development
-
Adalta Secures AD-214 Resupply Under KBI Biopharma MSA
The clinical resupply services will be delivered under AdAlta’s contract development and manufacturing Master Services Agreement with KBI Biopharma that was announced on 5 June 2018.